Skip to main content

Table 3 Unadjusted and adjusted odds of adverse events

From: Comparison of adverse events, prescription medication, and costs after hip, knee, and shoulder total joint arthroplasty: a retrospective cohort study

  

Unadjusted

 

Adjusteda

 

Outcome

TJA Group

OR (95% CI)

P-value

OR (95% CI)

P-value

Medical complications

90 days

Knee

0.97 (0.76, 1.24)

0.801

0.89 (0.68, 1.18)

0.427

 

Shoulder

1.24 (0.85, 1.80)

0.263

0.91 (0.60, 1.37)

0.65

 

Hip

REF

REF

REF

REF

365 days

     
 

Knee

1.08 (0.88, 1.33)

0.438

0.98 (0.78, 1.24)

0.878

 

Shoulder

1.66 (1.22, 2.25)

0.001

1.26 (0.90, 1.77)

0.186

 

Hip

REF

REF

REF

REF

Surgical complications

90 days

Knee

3.08 (2.38, 3.97)

 < 0.001

2.66 (2.03, 3.48)

 < 0.001

 

Shoulder

4.75 (3.38, 6.68)

 < 0.001

4.48 (3.16, 6.35)

 < 0.001

 

Hip

REF

REF

REF

REF

365 days

 

Knee

2.82 (2.21, 3.60)

 < 0.001

2.54 (1.97, 3.27)

 < 0.001

 

Shoulder

4.36 (3.13, 6.06)

 < 0.001

4.10 (2.92, 5.75)

 < 0.001

 

Hip

REF

REF

REF

REF

  1. aAdjusted for age, BMI, readmission score measured at baseline, and average daily MME of opioids within the time window of the endpoint of interest
Back to article page

Arthroplasty

ISSN: 2524-7948

Contact us